In people with obesity and established cardiovascular disease but without diabetes, semaglutide 2.4 mg resulted in 20% reduction in major adverse cardiovascular events [(MACE), death from cardiovascular causes, nonfatal myocardial infarction or nonfatal stroke] compared to placebo (SELECT trial) after a mean follow-up of 39.8 months this is the first trial demonstrating cardiovascular benefit for an obesity pharmacotherapy [110]
This product is formulated for quality and consistency and is commonly used in specialized wellness protocols under professional guidance
(did the FDA accidentally make this into an OTC supplement by adding it to the do not compound list?) So if it's so effective, why is it not approved by the FDA for human use
BPC-157 shows protective effects on the stomach lining by supporting mucosal integrity and promoting healing of ulcers in gastrointestinal models
Frequently Asked Questions It is used exclusively for laboratory and scientific research, including cellular studies, biochemical experiments, and peptide interaction research
Act against Folate deficiency: Asparagus is rich in vitamin K and Vitamin 9 (Folate)
